Terms: = Brain cancer AND PDGFRB, JTK12, 5159, P09619, ENSG00000113721, PDGF-R-beta, PDGFR1, CD140B, PDGFR, CD140b
238 results:
1. Regorafenib and glioblastoma: a literature review of preclinical studies, molecular mechanisms and clinical effectiveness.
Mongiardi MP; Pallini R; D'Alessandris QG; Levi A; Falchetti ML
Expert Rev Mol Med; 2024 Apr; 26():e5. PubMed ID: 38563164
[TBL] [Abstract] [Full Text] [Related]
2. Anlotinib alone or in combination with bevacizumab in the treatment of recurrent high-grade glioma: a prospective single-arm, open-label phase II trial.
Zhao S; Zhang M; Zhang Q; Wu J; Dai H
BMC Cancer; 2024 Jan; 24(1):6. PubMed ID: 38166698
[TBL] [Abstract] [Full Text] [Related]
3. Genetic alterations that deregulate RB and pdgfrA signaling pathways drive tumor progression in IDH2-mutant astrocytoma.
Tateishi K; Miyake Y; Nakamura T; Iwashita H; Hayashi T; Oshima A; Honma H; Hayashi H; Sugino K; Kato M; Satomi K; Fujii S; Komori T; Yamamoto T; Cahill DP; Wakimoto H
Acta Neuropathol Commun; 2023 Nov; 11(1):186. PubMed ID: 38012788
[TBL] [Abstract] [Full Text] [Related]
4. LncRNA INHEG promotes glioma stem cell maintenance and tumorigenicity through regulating rRNA 2'-O-methylation.
Liu L; Liu Z; Liu Q; Wu W; Lin P; Liu X; Zhang Y; Wang D; Prager BC; Gimple RC; Yu J; Zhao W; Wu Q; Zhang W; Wu E; Chen X; Luo J; Rich JN; Xie Q; Jiang T; Chen R
Nat Commun; 2023 Nov; 14(1):7526. PubMed ID: 37980347
[TBL] [Abstract] [Full Text] [Related]
5. Unveiling Novel Avenues in mTOR-Targeted Therapeutics: Advancements in Glioblastoma Treatment.
Singh S; Barik D; Lawrie K; Mohapatra I; Prasad S; Naqvi AR; Singh A; Singh G
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834408
[TBL] [Abstract] [Full Text] [Related]
6. Early Postnatal Expression of Tgfβ-1 and Fgf-2 Correlates With Regenerative Functions of Unrestricted Somatic Stem Cell Infusion After Rabbit GMH-IVH.
Finkel DA; Malfa A; Liao Y; Purohit D; Hu F; Sulaymankhil D; Abhishek Narra S; Hussein K; Subbian S; Cairo MS; Vinukonda G; La Gamma EF
Stem Cells Transl Med; 2023 Dec; 12(12):811-824. PubMed ID: 37774396
[TBL] [Abstract] [Full Text] [Related]
7. Tumor Treating Fields Alter the Kinomic Landscape in Glioblastoma Revealing Therapeutic Vulnerabilities.
Jones AB; Schanel TL; Rigsby MR; Griguer CE; McFarland BC; Anderson JC; Willey CD; Hjelmeland AB
Cells; 2023 Aug; 12(17):. PubMed ID: 37681903
[TBL] [Abstract] [Full Text] [Related]
8. Unraveling the signaling mechanism behind astrocytoma and possible therapeutics strategies: A comprehensive review.
Nahar Metu CL; Sutihar SK; Sohel M; Zohora F; Hasan A; Miah MT; Rani Kar T; Hossain MA; Rahman MH
Cancer Rep (Hoboken); 2023 Oct; 6(10):e1889. PubMed ID: 37675821
[TBL] [Abstract] [Full Text] [Related]
9. Increased pdgfrb and NF-κB signaling caused by highly prevalent somatic mutations in intracranial aneurysms.
Shima Y; Sasagawa S; Ota N; Oyama R; Tanaka M; Kubota-Sakashita M; Kawakami H; Kobayashi M; Takubo N; Ozeki AN; Sun X; Kim YJ; Kamatani Y; Matsuda K; Maejima K; Fujita M; Noda K; Kamiyama H; Tanikawa R; Nagane M; Shibahara J; Tanaka T; Rikitake Y; Mataga N; Takahashi S; Kosaki K; Okano H; Furihata T; Nakaki R; Akimitsu N; Wada Y; Ohtsuka T; Kurihara H; Kamiguchi H; Okabe S; Nakafuku M; Kato T; Nakagawa H; Saito N; Nakatomi H
Sci Transl Med; 2023 Jun; 15(700):eabq7721. PubMed ID: 37315111
[TBL] [Abstract] [Full Text] [Related]
10. Single-nucleus multiregion transcriptomic analysis of brain vasculature in Alzheimer's disease.
Sun N; Akay LA; Murdock MH; Park Y; Galiana-Melendez F; Bubnys A; Galani K; Mathys H; Jiang X; Ng AP; Bennett DA; Tsai LH; Kellis M
Nat Neurosci; 2023 Jun; 26(6):970-982. PubMed ID: 37264161
[TBL] [Abstract] [Full Text] [Related]
11. Analysis of stromal pdgfr-β and α-SMA expression and their clinical relevance in brain metastases of breast cancer patients.
Akanda MR; Ahn EJ; Kim YJ; Salam SMA; Noh MG; Lee TK; Kim SS; Lee KH; Moon KS
BMC Cancer; 2023 May; 23(1):468. PubMed ID: 37217880
[TBL] [Abstract] [Full Text] [Related]
12. Inhibition of extranodal NK/T-cell lymphoma by Chiauranib through an AIF-dependent pathway and its synergy with L-asparaginase.
Gao T; Huang J; Yin H; Huang J; Xie J; Zhou T; Fan W; Yang X; Gao G; Li Z
Cell Death Dis; 2023 May; 14(5):316. PubMed ID: 37160920
[TBL] [Abstract] [Full Text] [Related]
13. Sorting nexin 10 sustains PDGF receptor signaling in glioblastoma stem cells via endosomal protein sorting.
Gimple RC; Zhang G; Wang S; Huang T; Lee J; Taori S; Lv D; Dixit D; Halbert ME; Morton AR; Kidwell RL; Dong Z; Prager BC; Kim LJ; Qiu Z; Zhao L; Xie Q; Wu Q; Agnihotri S; Rich JN
JCI Insight; 2023 Mar; 8(6):. PubMed ID: 36795488
[TBL] [Abstract] [Full Text] [Related]
14. Cardiovascular morbidity following conventional therapy versus allogeneic hematopoietic stem cell transplantation after childhood, adolescent, and young adult leukemia in Finland.
Kero AE; Taskinen M; Volin L; Löyttyniemi E; Itälä-Remes M; Lähteenmäki PM
Int J Cancer; 2023 Jun; 152(11):2292-2302. PubMed ID: 36760204
[TBL] [Abstract] [Full Text] [Related]
15. Angiogenesis in hepatocellular carcinoma: mechanisms and anti-angiogenic therapies.
Yao C; Wu S; Kong J; Sun Y; Bai Y; Zhu R; Li Z; Sun W; Zheng L
Cancer Biol Med; 2023 Jan; 20(1):25-43. PubMed ID: 36647777
[TBL] [Abstract] [Full Text] [Related]
16. Growth factor receptor signaling induces mitophagy through epitranscriptomic regulation.
Lv D; Yang K; Rich JN
Autophagy; 2023 Mar; 19(3):1034-1035. PubMed ID: 35980802
[TBL] [Abstract] [Full Text] [Related]
17. Clinical outcomes of patients with multiple courses of radiosurgery for brain metastases from non-small cell lung cancer.
Lee WJ; Choi JW; Kong DS; Seol HJ; Nam DH; Lee JI
Sci Rep; 2022 Jun; 12(1):10712. PubMed ID: 35739135
[TBL] [Abstract] [Full Text] [Related]
18. PDGF signaling inhibits mitophagy in glioblastoma stem cells through N
Lv D; Gimple RC; Zhong C; Wu Q; Yang K; Prager BC; Godugu B; Qiu Z; Zhao L; Zhang G; Dixit D; Lee D; Shen JZ; Li X; Xie Q; Wang X; Agnihotri S; Rich JN
Dev Cell; 2022 Jun; 57(12):1466-1481.e6. PubMed ID: 35659339
[TBL] [Abstract] [Full Text] [Related]
19. PDGF-R inhibition induces glioblastoma cell differentiation via DUSP1/p38
Lane R; Cilibrasi C; Chen J; Shah K; Messuti E; Mazarakis NK; Stebbing J; Critchley G; Song E; Simon T; Giamas G
Oncogene; 2022 May; 41(19):2749-2763. PubMed ID: 35393545
[TBL] [Abstract] [Full Text] [Related]
20. Targeted therapy with anlotinib for a H3K27M mutation diffuse midline glioma patient with pdgfr-α mutation: a case report.
Wang Q; Niu W; Pan H
Acta Neurochir (Wien); 2022 Aug; 164(8):2063-2066. PubMed ID: 34812950
[TBL] [Abstract] [Full Text] [Related]
[Next]
